In Nanologica’s stock option program 2018/21 exercise of rights in Nanologica’s stock option program has increased the number of shares in the company by 371,346 to 28,165,826 shares. As a result, the share capital increases to SEK 11,548,761.
At Nanologica’s Annual General Meeting on May 31, 2018, it was resolved to establish an incentive program of a maximum of 484,883 stock options for the company’s employees. Each option entitles the holder to subscribe for one share in the company at a subscription price corresponding to SEK 9.3 during the period 1 July 2018 to 1 July 2021. A total of 467,199 options were subscribed for in the program.
As a result of 371,346 options being exercised by the option holders during June, the total number of shares in Nanologica AB increases to 28,165,826 and the share capital increases to SEK 11,548,761. The company receives TSEK 3,454 as payment from the option holders upon exercising of the options. Registration of the shares and share capital is ongoing but not completed at the time for the publication of this press release.
The option program expires on July 1, 2021.
For further information, please contact:
Johanna Johansson, IR Nanologica
Ph: +46 72 211 21 90
About Nanologica AB (publ)
Nanologica manufactures, develops, and sells nanoporous silica particles for applications within life science. Nanologica is world-leading in controlling the shape, size, porosity, and surface characteristics of silica particles. Through the two business areas, Drug Development and Chromatography, the company strives towards reducing healthcare disparities throughout the world for the betterment of mankind. In Drug Development, the company is committed to leverage its technology platform to solve medical problems in order to provide new treatments for patients with severe lung diseases. In Chromatography, the aim is to make insulin available to more patients in need by reducing the production cost for manufacturers. Nanologica operates from the headquarters in Södertälje, Sweden and Nanologica’s stock (NICA) is listed on Spotlight Stock Market. For further information, please visit www.nanologica.com.